Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Ischemia | 13 | 2024 | 2148 | 2.780 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2023 | 1066 | 1.200 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 2 | 2024 | 293 | 0.850 |
Why?
|
| Arterioles | 2 | 2022 | 254 | 0.800 |
Why?
|
| Heart Arrest, Induced | 1 | 2022 | 355 | 0.760 |
Why?
|
| Swine | 13 | 2024 | 5917 | 0.740 |
Why?
|
| Coronary Circulation | 5 | 2023 | 1572 | 0.710 |
Why?
|
| Receptors, Serotonin | 1 | 2018 | 201 | 0.610 |
Why?
|
| Myocardium | 11 | 2024 | 4776 | 0.550 |
Why?
|
| Vasoconstriction | 1 | 2018 | 597 | 0.520 |
Why?
|
| Perfusion | 3 | 2023 | 1360 | 0.480 |
Why?
|
| Coronary Vessels | 2 | 2023 | 3107 | 0.470 |
Why?
|
| Hypertension | 2 | 2023 | 8480 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2023 | 3537 | 0.400 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 18029 | 0.390 |
Why?
|
| Neovascularization, Physiologic | 2 | 2023 | 1351 | 0.270 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5034 | 0.250 |
Why?
|
| Phorbols | 1 | 2024 | 43 | 0.240 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 5751 | 0.240 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2023 | 68 | 0.240 |
Why?
|
| Thromboxane A2 | 1 | 2023 | 92 | 0.240 |
Why?
|
| Calpain | 2 | 2023 | 150 | 0.230 |
Why?
|
| Angiostatins | 1 | 2022 | 67 | 0.220 |
Why?
|
| Phenylephrine | 1 | 2022 | 301 | 0.200 |
Why?
|
| Symporters | 1 | 2023 | 362 | 0.190 |
Why?
|
| Glycoproteins | 2 | 2020 | 2263 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2022 | 689 | 0.180 |
Why?
|
| Animals | 14 | 2024 | 168757 | 0.170 |
Why?
|
| Fibrosis | 2 | 2022 | 2029 | 0.160 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 935 | 0.160 |
Why?
|
| Microvessels | 1 | 2022 | 544 | 0.150 |
Why?
|
| Microcirculation | 1 | 2022 | 1286 | 0.150 |
Why?
|
| Interleukin-10 | 1 | 2022 | 1200 | 0.140 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2016 | 190 | 0.140 |
Why?
|
| Protein Kinases | 1 | 2022 | 1640 | 0.130 |
Why?
|
| Antioxidants | 1 | 2022 | 1663 | 0.120 |
Why?
|
| Collagen | 2 | 2020 | 2689 | 0.120 |
Why?
|
| Serotonin | 1 | 2018 | 1017 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2022 | 2499 | 0.110 |
Why?
|
| Endothelium, Vascular | 2 | 2024 | 4456 | 0.110 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 1224 | 0.110 |
Why?
|
| Ventricular Function, Right | 1 | 2016 | 591 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3200 | 0.110 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2023 | 1632 | 0.100 |
Why?
|
| Myocardial Infarction | 2 | 2023 | 11727 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2023 | 3086 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1972 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 581 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4420 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2023 | 8324 | 0.090 |
Why?
|
| Vasodilation | 2 | 2024 | 944 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 4258 | 0.070 |
Why?
|
| Mitochondria | 1 | 2018 | 3520 | 0.060 |
Why?
|
| Humans | 11 | 2024 | 744343 | 0.060 |
Why?
|
| Myristates | 1 | 2024 | 13 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 1912 | 0.060 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2024 | 45 | 0.060 |
Why?
|
| Protein Carbonylation | 1 | 2023 | 29 | 0.060 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2023 | 78 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2016 | 5007 | 0.060 |
Why?
|
| Endostatins | 1 | 2023 | 174 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4931 | 0.060 |
Why?
|
| Acetates | 1 | 2024 | 311 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2024 | 481 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2023 | 1420 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21746 | 0.050 |
Why?
|
| Proteomics | 2 | 2024 | 3638 | 0.050 |
Why?
|
| NAD | 1 | 2024 | 593 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2020 | 182 | 0.040 |
Why?
|
| Glycolysis | 1 | 2023 | 827 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2023 | 2327 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 617 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 996 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 528 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2077 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2023 | 1809 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2024 | 3505 | 0.030 |
Why?
|
| Ischemia | 1 | 2023 | 1907 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2023 | 2289 | 0.030 |
Why?
|
| Proteome | 1 | 2024 | 1799 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2938 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2020 | 1151 | 0.030 |
Why?
|
| Aged | 3 | 2023 | 163280 | 0.030 |
Why?
|
| Male | 5 | 2023 | 350118 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 3508 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 2872 | 0.020 |
Why?
|
| Glucose | 1 | 2023 | 4397 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3479 | 0.020 |
Why?
|
| Middle Aged | 3 | 2023 | 213383 | 0.020 |
Why?
|
| Risk Factors | 3 | 2023 | 72290 | 0.020 |
Why?
|
| Female | 4 | 2023 | 380194 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1889 | 0.020 |
Why?
|
| Rats | 1 | 2023 | 24260 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 6770 | 0.020 |
Why?
|
| Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
| Cytokines | 1 | 2016 | 7322 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9146 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9727 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5535 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15076 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6487 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 63114 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2020 | 23403 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81183 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29063 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39050 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 40561 | 0.010 |
Why?
|
Concepts
(109)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_